In individual patient samples analyzed, we identified and quantified 4 components (C1S, C4B, C1QB, C1QC) which are seen with activation of the complement cascade and which were differentially increased in abundance consistently across the nPTLS patients compared to CFS (Figure S1B and C). This evidence concerns the gene C1QC and myalgic encephalomeyelitis/chronic fatigue syndrome.